The long term objective of this research program is to use cell-specific cytotoxic natural products as vehicles to advance the fields of complex molecule synthesis and drug discovery. These goals will require an interdisciplinary approach to define the mechanistic basis by which these natural products selectively target cancer cells using the tools of chemical biology, relying primarily upon the power of chemical synthesis. As such, contributions from our laboratory will focus on the development of efficient and stereocontrolled strategies for the synthesis of complex natural products and their respective congeners of interest. Collaborative efforts will allow us to develop SAR profiles that will ultimately lead to identification of the cellular target for the secondary metabolites that we intend to study.
Specific Aims for the forthcoming grant period include: (1) Chemical synthesis azido apoptolidinone;(2) Development of procedures for the enzymatic glycosylation of the unnatural aglycones using precursor directed biosynthesis in collaboration with Professor Brian Bachmann (Vanderbilt Institute of Chemical Biology);(3) Stereocontrolled synthesis of ammocidin, a polyketide derived natural product that selectively induces apoptosis in ras-dependent cells;(4) Identification of the cellular target(s) of apoptolidin and hibarimicin E using a chemical proteomics strategy in collaboration with Professors Dan Liebler and Larry Marnett (Vanderbilt Institute of Chemical Biology);(5) Chemical synthesis of hibarimicinone and the hibarimicin shunt metabolite HMP-Y1. Lay language description: One long term objective is to develop methods for the assembly of a group of natural products that have proven to selectively eliminate cancer cells without harming normal cells. A second objective is to use various chemical and biochemical tools to understand, at a molecular level, how these compounds target cancer cells. Advances in this area could have significant impact in the treatment of cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Lees, Robert G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Schools of Medicine
United States
Zip Code
Chong, Katherine M; Leelatian, Nalin; Deguire, Sean M et al. (2016) The use of fluorescently-tagged apoptolidins in cellular uptake and response studies. J Antibiot (Tokyo) 69:327-30
DeGuire, Sean M; Earl, David C; Du, Yu et al. (2015) Fluorescent probes of the apoptolidins and their utility in cellular localization studies. Angew Chem Int Ed Engl 54:961-4
Romaine, Ian M; Sulikowski, Gary A (2015) Studies on a biomimetic oxidative dimerization approach to the hibarimicins. Tetrahedron Lett 56:3617-3619
Baranczak, Aleksandra; Sulikowski, Gary A (2012) Synthetic studies directed toward dideoxy lomaiviticinone lead to unexpected 1,2-oxazepine and isoxazole formation. Org Lett 14:1027-9
Baranczak, Aleksandra; Sulikowski, Gary A (2012) Cascade assembly of the benzo[a]anthraquinone ring system common to the angucycline antibiotics. Tetrahedron Lett 53:1345-1346
Chau, Stephen T; Hayakawa, Yoichi; Sulikowski, Gary A (2011) 18O assisted analysis of a ?,?-epoxyketone cyclization: synthesis of the C16-C28 fragment of ammocidin D. Org Lett 13:756-9
Romaine, Ian M; Hempel, Jonathan E; Shanmugam, Ganesh et al. (2011) Assignment and stereocontrol of hibarimicin atropoisomers. Org Lett 13:4538-41
DeGuire, Sean M; Ma, Shutao; Sulikowski, Gary A (2011) Synthesis of a bicyclobutane fatty acid identified from the cyanobacterium Anabaena PCC 7120. Angew Chem Int Ed Engl 50:9940-2
Du, Yu; Derewacz, Dagmara K; Deguire, Sean M et al. (2011) Biosynthesis of the Apoptolidins in Nocardiopsis sp. FU 40. Tetrahedron 67:6568-6575
Bachmann, Brian O; McNees, Ruth; Melancon, Bruce J et al. (2010) Light-induced isomerization of apoptolidin a leads to inversion of C2-C3 double bond geometry. Org Lett 12:2944-7

Showing the most recent 10 out of 13 publications